Supporting Sustainable Implementation of HIV and TB Services for Epidemic Control in The Republic of Mozambique under the President’s Emergency Plan for AIDS Relief (PEPFAR) | CDC RFA GH16 163202CONT17

Opportunity Information: Apply for CDC RFA GH16 163202CONT17

This funding opportunity, titled "Supporting Sustainable Implementation of HIV and TB Services for Epidemic Control in The Republic of Mozambique under the President's Emergency Plan for AIDS Relief (PEPFAR)," is a U.S. government health grant focused on strengthening and sustaining HIV and tuberculosis (TB) service delivery in Mozambique as part of broader epidemic control goals. It is issued by the U.S. Department of Health and Human Services (HHS), through the Centers for Disease Control and Prevention (CDC), specifically the CDC Center for Global Health (CGH). The opportunity sits within the public health funding domain and is aligned with PEPFAR, the U.S. initiative that supports HIV prevention, treatment, and health system strengthening in partner countries.

The announcement is identified by Funding Opportunity Number CDC RFA GH16-163202CONT17 and is categorized as a continuation opportunity. In practical terms, "continuation" typically indicates support for ongoing or previously established program activities rather than a brand-new, open competition designed to launch entirely new projects. The funding instrument is a cooperative agreement, which generally means the CDC expects to have substantial involvement in the funded work. Instead of operating purely as a pass-through funder, CDC staff commonly provide technical direction, participate in planning and monitoring, and collaborate with recipients to ensure activities stay aligned with PEPFAR strategies, national priorities, and performance expectations.

The program area is health (CFDA 93.067), and the core purpose is to support implementation of HIV and TB services that can be sustained over time and that contribute to epidemic control in Mozambique. While the short description does not list specific interventions, the title itself signals an emphasis on integrated HIV and TB efforts, which often includes strengthening HIV testing and linkage to care, expanding antiretroviral therapy coverage and retention, improving viral load monitoring and suppression, preventing new infections, and ensuring that TB prevention, detection, and treatment are effectively delivered alongside HIV services. Because TB is a leading cause of illness and death among people living with HIV, PEPFAR-supported programs frequently prioritize TB/HIV collaboration, such as TB screening among HIV patients, TB preventive treatment where appropriate, and rapid diagnosis and treatment initiation for TB, including drug-resistant TB when relevant.

The opportunity was created on February 2, 2017, with an original closing date of April 4, 2017, indicating a time-limited application window typical of federal awards. The expected number of awards is listed as 10, suggesting CDC anticipated supporting multiple implementing partners or consortia working across different provinces, service delivery platforms, or technical areas within Mozambique. The award ceiling is listed as 0, which usually means the ceiling was not specified in the summary data and that applicants would need to consult the full notice for budget guidance, funding ranges, or limitations. In many CDC cooperative agreements under PEPFAR, funding levels can vary widely depending on the scope of work, geographic coverage, and whether the recipient is responsible for direct service delivery, technical assistance, health systems strengthening, monitoring and evaluation, or a combination of these.

Eligibility is marked broadly as "Others," with a note to see the full announcement for clarification. That kind of eligibility label often appears when the funding is not limited to a single applicant type (such as only universities or only nonprofits) or when there are special constraints typical of continuation or restricted competitions. Depending on the detailed eligibility language, "others" can encompass a range of organizations such as nongovernmental organizations, faith-based organizations, academic institutions, for-profit entities, and potentially international organizations, provided they meet CDC requirements and any PEPFAR-related conditions. Because it is a continuation opportunity, eligibility may have been limited to existing recipients or partners already funded under the preceding award, but that determination would come from the full eligibility section.

Overall, the grant is best understood as part of CDC's PEPFAR-supported portfolio in Mozambique aimed at ensuring HIV and TB services are not only delivered at scale, but also implemented in a way that is durable and locally owned. The focus on "sustainable implementation" implies attention to long-term system capacity, such as strengthening national and subnational program management, improving service quality, building laboratory and supply chain systems, enhancing data systems for patient and program monitoring, and supporting workforce development. The "epidemic control" framing points to measurable population-level outcomes, commonly including increased treatment coverage, higher rates of viral suppression, and reduced HIV incidence, alongside improved TB case detection and treatment success, especially among people living with HIV.

• The Department of Health and Human Services, Centers for Disease Control - CGH in the health sector is offering a public funding opportunity titled "Supporting Sustainable Implementation of HIV and TB Services for Epidemic Control in The Republic of Mozambique under the President’s Emergency Plan for AIDS Relief (PEPFAR)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
• This funding opportunity was created on Feb 02, 2017.
• Applicants must submit their applications by Apr 04, 2017. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 10 candidate(s).
• Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).

Apply for CDC RFA GH16 163202CONT17

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: